AGP Executive Report
Last update: 12 hours agoHeart Health: A study of more than 50 million hospital records linked recreational cannabis legalization in the western US to faster rises in admissions for heart attacks, heart failure and atrial fibrillation. The findings show an association, not cause and effect. Sleep and Safety: Researchers found tolerance and withdrawal signs in mice given CBN, a cannabis compound marketed for sleep, for three days. The results raise questions about repeated use but don’t establish risks in people. Pregnancy: Another study linked cannabis addiction during pregnancy to a higher risk of postpartum psychiatric crises, underscoring the need for more research and support. CBD Regulation: Industry voices warn that proposed federal hemp restrictions could threaten full-spectrum CBD products. Treatment Research: Clinical trials are under way for a cannabis-based pain medicine, while a new review examines what science can—and can’t—say about CBD and cannabis for insomnia.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
